Bibliographie

1– UK Prospective Diabetes Study (UKPDS) Group. Intensive Blood-Glucose Control with Sulfonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). The Lancet 1998 ; 352 : 837-53.

2– Adler A.-I.,Stratton I.-M. et al. Association of Systolic Blood Pressure with Macrovascular and Microvascular complications of Type 2 Diabetes (UKPDS 36) : Prospective Observational Study.

BMJ. 2000 Aug ; 321 (7258) : 412 – 419.

3– Holman R.-R., Paul S.-K., Bethel M.-A. et al. 10-year Follow-up of Intensive Glucose Control in type 2 Diabetes. N Engl J Med 2008 ; 359 : 1577-89.

4– Holman R.-R., Paul S.-K., Bethel M.-A. et al. Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes. N Engl J Med 2008 ; 359 : 1565-76.

5– Gerstein H.-C., Miller M.-E., Byington R.-P. et al. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008 ; 358 : 2545-59.

6– Duckworth W., Abraira C., Moritz T. et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009 ; 360/ 129 – 39.

7– The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2008 ; 358(24) :2560-257.

8– Afssaps-HAS. Recommandation Professionnelle. Traitement médicamenteux du diabète de type 2 (actualisation). Novembre 2006. Recommandation de bonne pratique (synthèse et recommandations). Diabetes Metab 2007 ; 33 : 1S1-1S105

9– Valensi P., Benroubi M., Borzi V. et al. IMPROVE Study Group Expert Panel.The IMPROVE study – A Multinational, Observational Study in Type 2 Diabetes : Baseline Characteristics from eight National Cohorts. Int J Clin Pract. 2008 Nov ; 62(11) : 1809-19. Epub 2008 Sep 22.

10– Gaede P., Vedel P., Parving H.-H., Pedersen O. Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus and Microalbuminuria : the Steno Type 2 Randomised Study. The Lancet 1999 ; 353 : 617-22.